Company Overview
Team Members
Technologies
Email Formats
Competitors
Faqs

10 free leads on us

Use our Chrome Extension & instantly connect with prospects

Download Free
Use Google
crystals

Find Contacts

Homepage  >  Business Services  > 

Royalty Pharma

Company Name

Royalty Pharma

Main Industry

Business Services, Research & Development

Website

www.royaltypharma.com

Contact Information

Headquarters

110 E 59th Street Fl. 33, New York City, New York, 10022, United States

(212) 883-0200

New York City, New York Office

180 Varick St, Fl 2, New York City, New York, 10014, United States

(212) 883-6772

New York City, New York Office

675 3rd Ave, Ste 3000, New York City, New York, 10021, United States

(212) 883-2295

Royalty Pharma Profile and History

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalti es which entitles it to payments based directly on the top-line sales of many of the industry's leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma's current portfolio includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Johnson & Johnsons' Tremfya, Astellas' and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates.

...Read More

Royalty Pharma Plc

Royalty Pharma

Royalty Pharma AG

Royalty Pharma Investor Relations and Communicatio...

RP Management LLC

Revenue

$2.3 B

Employees

66

Founded

1996

Stock Symbol

NASDAQ: RPRX

Royalty Pharma Executive Team & Key Decision Makers

Name & TitleContact Info
Marshall Urist
Marshall Urist

Head Executive VP, Co-, Research & Investments

❅❅❅❅@royaltypharma.com

(917) ❅❅❅-❅❅❅❅

Visit Profile

Christopher Hite
Christopher Hite

Executive Vice President & Vice Chairman

❅❅❅❅@royaltypharma.com

(917) ❅❅❅-❅❅❅❅

Visit Profile

Sean Weisberg
Sean Weisberg

Vice President, Capital Markets & Deputy General Counsel

❅❅❅❅@royaltypharma.com

(415) ❅❅❅-❅❅❅❅

Visit Profile

Jason Mehar
Jason Mehar

Vice President, Investments & Deputy General Counsel

(646) ❅❅❅-❅❅❅❅

Visit Profile

Jessica Veeramachaneni
Jessica Veeramachaneni

Vice President & Controller

Visit Profile

Oodaye Shukla
Oodaye Shukla

Vice President, Strategy & Analytics

(610) ❅❅❅-❅❅❅❅

Visit Profile

James Reddoch
James Reddoch

Head Executive VP, Research & Investments, Ph D

❅❅❅❅@royaltypharma.com

(917) ❅❅❅-❅❅❅❅

Visit Profile

Vlad Nikolenko
Vlad Nikolenko

Investments Vice President, Research

❅❅❅❅@royaltypharma.com

(917) ❅❅❅-❅❅❅❅

Visit Profile

Sandy Balkin
Sandy Balkin

Senior VP, Strategy & Analytics

❅❅❅❅@royaltypharma.com

(347) ❅❅❅-❅❅❅❅

Visit Profile

Terrance Coyne
Terrance Coyne

Senior Vice President

❅❅❅❅@royaltypharma.com

(267) ❅❅❅-❅❅❅❅

Visit Profile

Dana Flanders
Dana Flanders

Vice President, Investor Relations & Communications

❅❅❅❅@royaltypharma.com

(203) ❅❅❅-❅❅❅❅

Visit Profile

Scott Raichilson
Scott Raichilson

Vice President, Transactional & Technical Accounting

❅❅❅❅@royaltypharma.com

(440) ❅❅❅-❅❅❅❅

Visit Profile

Recently Updated Team Members

Name & TitleContact Info
Xico Gracida
Xico Gracida

Strategy & Analytics Associate

❅❅❅❅@royaltypharma.com

Visit Profile

Scott Raichilson
Scott Raichilson

Vice President, Transactional & Technical Accounting

❅❅❅❅@royaltypharma.com

(440) ❅❅❅-❅❅❅❅

Visit Profile

Sean Weisberg
Sean Weisberg

Vice President, Capital Markets & Deputy General Counsel

❅❅❅❅@royaltypharma.com

(415) ❅❅❅-❅❅❅❅

Visit Profile

Sam Landsberg
Sam Landsberg

Financial Planning Vice President, Strategy

(857) ❅❅❅-❅❅❅❅

Visit Profile

Sam Glazer
Sam Glazer

Research & Investments Associate

❅❅❅❅@royaltypharma.com

(203) ❅❅❅-❅❅❅❅

Visit Profile

Jason Mehar
Jason Mehar

Vice President, Investments & Deputy General Counsel

(646) ❅❅❅-❅❅❅❅

Visit Profile

Christine Grueniger
Christine Grueniger

Assistant Controller

❅❅❅❅@royaltypharma.com

(646) ❅❅❅-❅❅❅❅

Visit Profile

Alberto Sepulveda
Alberto Sepulveda

Strategy & Analytics Associate

❅❅❅❅@royaltypharma.com

(917) ❅❅❅-❅❅❅❅

Visit Profile

Terrance Coyne
Terrance Coyne

Senior Vice President

❅❅❅❅@royaltypharma.com

(267) ❅❅❅-❅❅❅❅

Visit Profile

Dana Flanders
Dana Flanders

Vice President, Investor Relations & Communications

❅❅❅❅@royaltypharma.com

(203) ❅❅❅-❅❅❅❅

Visit Profile

Kaitlyn Devine
Kaitlyn Devine

Finance & Capital Markets Senior Associate

❅❅❅❅@royaltypharma.com

Visit Profile

Sandy Balkin
Sandy Balkin

Senior VP, Strategy & Analytics

❅❅❅❅@royaltypharma.com

(347) ❅❅❅-❅❅❅❅

Visit Profile

Christopher Hite
Christopher Hite

Executive Vice President & Vice Chairman

❅❅❅❅@royaltypharma.com

(917) ❅❅❅-❅❅❅❅

Visit Profile

Sara Klymkowsky
Sara Klymkowsky

Investments Vice President, Research

❅❅❅❅@royaltypharma.com

(720) ❅❅❅-❅❅❅❅

Visit Profile

Top Royalty Pharma Integrations and Technologies

Here's a list of some of the top trending technologies and APIs used by Royalty Pharma.

Web Analytics

(3 Technologies)

Web Content Management Systems

(3 Technologies)

Real User Monitoring

(2 Technologies)

Domain Name Services

(1 Technologies)

Tag Management

(1 Technologies)

Royalty Pharma Email Formats

ParameterSample EmailPercentage

Royalty Pharma Top Competitors

CompanyEmployeesRevenueTop technologies
DRI Capital

DRI Capital

30$14.4 M
Aisling Capital

Aisling Capital

26$4.4 M
Alaris Royalty

Alaris Royalty

23$73.4 M
Lindsay Goldberg

Lindsay Goldberg

92$47.4 M
Sagard

Sagard

28$6 M

What is Royalty Pharma revenue?

Royalty Pharma revenue is $2.3 B

How many employees does Royalty Pharma have?

Royalty Pharma has 66 employees

Where is Royalty Pharma headquarters located?

Royalty Pharma headquarters are located in 110 E 59th Street Fl. 33, New York City, New York, 10022, United States

What are Royalty Pharma’s primary industries?

Royalty Pharma’s main industries are: Business Services, Research & Development, Finance

Who is Royalty Pharma’s CEO?

Royalty Pharma’s CEO is Pablo Legorreta

What are some additional names or alternative spellings that users use while searching for Royalty Pharma?

Royalty Pharma appears in search results as Royalty Pharma Plc, Royalty Pharma, Royalty Pharma AGRoyalty Pharma Investor Relations and Communicatio..., RP Management LLC...See More